EORTC Radiation Oncology Group

 

Home Working parties ROG EORTC HQ Team On-Going ROG trials Group meetings Quality assurance EORTC-ROG Guidelines YROG For Members only RT Technologists About us Achievements
 

head & neck

 

 

22071-24071

Randomized phase III trial on postoperative chemoradiation in combination with an EGFR-antibody versus postoperative chemoradiation in head and neck squamous cell carcinoma (HNSCC) with high risk of locoregional recurrence (W. Budach, H.Langendijk)

design

         
         
 

 

 

 

 

 

 Trial Status on 11.2010 archives